BELLEVUE, Wash.--(BUSINESS WIRE)--June 5, 2006--SCOLR Pharma, Inc. (AMEX: DDD - News) today announced that its once daily CDT® based Glucosamine/Chondroitin private label product will be marketed by a significant number of the nation’s largest retailers.
